Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial.

Kim, Jae-Hong; Cho, Myoung-Rae; Yoo, Jaehee; Park, Gwang-Cheon; Lee, Jeong-Soon

Kim, Jae-Hong; Cho, Myoung-Rae; Yoo, Jaehee; Park, Gwang-Cheon; Lee, Jeong-Soon.

Afiliação

Kim JH; Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Dongshin University, Naju, Republic of Korea; Clinical Research Center, Dongshin University Gwangju Korean Medicine Hospital, Gwangju, Republic of Korea.
Cho MR; Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Dongshin University, Naju, Republic of Korea.
Yoo J; Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Dongshin University, Naju, Republic of Korea.
Park GC; Clinical Research Center, Dongshin University Gwangju Korean Medicine Hospital, Gwangju, Republic of Korea.
Lee JS; Department of Nursing, Christian College of Nursing, Gwangju, Republic of Korea.

Ann Palliat Med ; 11(10): 3320-3329, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36267013

Assuntos

Doença de Alzheimer; Disfunção Cognitiva; Humanos; Idoso; Atividades Cotidianas; Estudos Prospectivos; Qualidade de Vida; Disfunção Cognitiva/tratamento farmacológico; Disfunção Cognitiva/psicologia; Resultado do Tratamento; Cognição; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

Mild cognitive impairment (MCI); Tennohosintan; Tian Wang Bu Xin Dan; cheonwangbosimdan; randomized controlled trial (RCT)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Aged / Humans Idioma: En Revista: Ann Palliat Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google